Download FREE Report Sample
Download Free sampleDuchenne Muscular Dystrophy Drugs Market contains market size and forecasts of Duchenne Muscular Dystrophy Drugs in Global, including the following market information:
Global Duchenne Muscular Dystrophy Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Duchenne Muscular Dystrophy Drugs market was valued at 1041.1 million in 2021 and is projected to reach US$ 7464.7 million by 2028, at a CAGR of 32.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Molecular-based Therapies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Duchenne Muscular Dystrophy Drugs include Biogen, Roche, Daiichi Sankyo, Pfizer, Cumberland Pharmaceuticals, Santhera Pharmaceuticals, Taiho Pharmaceutical, Teijin Pharma and Akashi Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Duchenne Muscular Dystrophy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Duchenne Muscular Dystrophy Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Duchenne Muscular Dystrophy Drugs Market Segment Percentages, by Type, 2021 (%)
Molecular-based Therapies
Steroid Therapy
Other
Global Duchenne Muscular Dystrophy Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Duchenne Muscular Dystrophy Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Duchenne Muscular Dystrophy Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Duchenne Muscular Dystrophy Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Duchenne Muscular Dystrophy Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Duchenne Muscular Dystrophy Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Roche
Daiichi Sankyo
Pfizer
Cumberland Pharmaceuticals
Santhera Pharmaceuticals
Taiho Pharmaceutical
Teijin Pharma
Akashi Therapeutics
Sarepta Therapeutics
BioMarin
Fibrogen Inc
Nobelpharma Co. Ltd
Eloxx Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
